Black Rock Inc. Veracyte, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,793,059 shares of VCYT stock, worth $303 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,793,059
Previous 7,211,371
8.07%
Holding current value
$303 Million
Previous $160 Million
5.68%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Vanguard Group Inc Valley Forge, PA7.75MShares$302 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$196 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$192 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$165 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.03MShares$118 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.79B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...